Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.16 | -2.47493065927 | 46.87 | 47.09 | 43.84 | 642715 | 45.12624662 | CS |
4 | -3.81 | -7.69386106624 | 49.52 | 50 | 43.32 | 629618 | 46.23270048 | CS |
12 | -5.52 | -10.7749365606 | 51.23 | 60.92 | 43.32 | 628748 | 51.90044086 | CS |
26 | 5.98 | 15.0515982884 | 39.73 | 60.92 | 39.63 | 569495 | 50.37786529 | CS |
52 | 9.8 | 27.2904483431 | 35.91 | 60.92 | 35.7 | 491059 | 47.48803966 | CS |
156 | 45.285 | 10655.2941176 | 0.425 | 60.92 | 0.1302 | 717405 | 15.65128067 | CS |
260 | 42.96 | 1562.18181818 | 2.75 | 60.92 | 0.1302 | 797843 | 9.09122361 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions